Acceso usuarios
Virtual reality for psychosocial remediation in schizophrenia: a systematic review
Patricia Fernández Sotos, Antonio Fernández Caballero, Roberto Rodríguez Jiménez
págs. 1-10
Neuregulin1 gene variants as a biomarker for cognitive impairments in patients with schizophrenia
E.S. Ananloo, S. Yoosefee, M. Karimipour
págs. 11-19
The impact of cancer treatment on cognitive efficiency: Chemobrain – does it exist?
M. Kuśmierek, J. Jasionowska, P. Maruszewska, E. Kalinka-Warzocha, P. Galecki, I. Mikołajczyk, M. Talarowska
págs. 20-26
The effects of psychosocial day care program on clinical symptoms and quality of life of persons with depression: a prospective study
Tanja Grahovac Juretić, Marina Letica-Crepulja, Aleksandra Stefanovic, Klementina Ružić, Ika Rončević-Gržeta, Ana Došen
págs. 27-35
Utilization of healthcare and psychotropic medication in elderly and non-elderly people with first self-poisoning episodes: A nationwide population-based cohort study
C.-Y. Wu, C.K. Chang, Fei Yuan Hsiao, Y.W. Lin, S.I. Wu, K.L. Kao
págs. 36-43
The new Horizon Europe programme 2021–2028: Should the gap between the burden of mental disorders and the funding of mental health research be filled?
G. Castelpietra, A. Nicotra, L. Pischiutta, Mencía Ruiz Gutiérrez-Colosía, Josep Maria Haro Abad, Luis Salvador Carulla
págs. 44-46
The implementation of a physical health checklist in a psychiatric forensic unit
G. Xuereb, K. Apap, J. Borg
págs. 47-50
págs. 51-51
